Artelo Biosciences, Inc. (ARTL)

USD 0.85

(-6.94%)

Operating Income Summary of Artelo Biosciences, Inc.

  • Artelo Biosciences, Inc.'s latest annual operating income in 2022 was -10.28 Million USD , down -38.25% from previous year.
  • Artelo Biosciences, Inc.'s latest quarterly operating income in 2023 Q2 was -1.78 Million USD , up 22.16% from previous quarter.
  • Artelo Biosciences, Inc. reported an annual operating income of -7.44 Million USD in 2021, down -58.8% from previous year.
  • Artelo Biosciences, Inc. reported an annual operating income of -4.68 Million USD in 2020, down -46.0% from previous year.
  • Artelo Biosciences, Inc. reported a quarterly operating income of -2.29 Million USD for 2023 Q1, up 34.06% from previous quarter.
  • Artelo Biosciences, Inc. reported a quarterly operating income of -1.78 Million USD for 2023 Q2, up 22.16% from previous quarter.

Annual Operating Income Chart of Artelo Biosciences, Inc. (2022 - 2014)

Historical Annual Operating Income of Artelo Biosciences, Inc. (2022 - 2014)

Year Operating Income Operating Income Growth
2022 -10.28 Million USD -38.25%
2021 -7.44 Million USD -58.8%
2020 -4.68 Million USD -46.0%
2019 -3.2 Million USD -36.96%
2018 -2.34 Million USD -906.7%
2017 -232.78 Thousand USD -684.07%
2016 -29.69 Thousand USD -94.8%
2015 -15.24 Thousand USD 0.18%
2014 -15.26 Thousand USD 0.0%

Peer Operating Income Comparison of Artelo Biosciences, Inc.

Name Operating Income Operating Income Difference
AbCellera Biologics Inc. -237.2 Million USD 95.663%
Alkermes plc 414.12 Million USD 102.484%
Agenus Inc. -159.54 Million USD 93.552%
Aptorum Group Limited -10.52 Million USD 2.246%
Ardelyx, Inc. -63.27 Million USD 83.743%
Dyadic International, Inc. -8.22 Million USD -24.998%
Eton Pharmaceuticals, Inc. -1.19 Million USD -763.003%
Lantern Pharma Inc. -17.87 Million USD 42.459%
Inhibikase Therapeutics, Inc. -20.08 Million USD 48.795%
Novavax, Inc. -566.51 Million USD 98.184%
Janux Therapeutics, Inc. -72.97 Million USD 85.904%
Pyxis Oncology, Inc. -82.19 Million USD 87.485%
TransCode Therapeutics, Inc. -19.41 Million USD 47.025%
Ocuphire Pharma, Inc. -10.56 Million USD 2.613%
Outlook Therapeutics, Inc. -53.12 Million USD 80.637%
Madrigal Pharmaceuticals, Inc. -380.49 Million USD 97.296%
Reviva Pharmaceuticals Holdings, Inc. -24.3 Million USD 57.678%
SELLAS Life Sciences Group, Inc. -37.86 Million USD 72.835%
Syros Pharmaceuticals, Inc. -128.98 Million USD 92.025%
Barinthus Biotherapeutics plc -83.91 Million USD 87.741%
Windtree Therapeutics, Inc. -17.53 Million USD 41.348%
Xeris Biopharma Holdings, Inc. -44.01 Million USD 76.626%
Clearside Biomedical, Inc. -24.84 Million USD 58.594%
C4 Therapeutics, Inc. -139.03 Million USD 92.601%
Alnylam Pharmaceuticals, Inc. -282.17 Million USD 96.354%
AlloVir, Inc. -181.33 Million USD 94.327%
Arrowhead Pharmaceuticals, Inc. -205 Million USD 94.982%
VYNE Therapeutics Inc. -29.25 Million USD 64.84%
Bicycle Therapeutics plc -189.94 Million USD 94.584%
BioXcel Therapeutics, Inc. -171.78 Million USD 94.012%
ChromaDex Corporation -5.59 Million USD -83.729%
Chimerix, Inc. -93.06 Million USD 88.946%
Corbus Pharmaceuticals Holdings, Inc. -45.07 Million USD 77.179%
Caribou Biosciences, Inc. -116.05 Million USD 91.136%
CRISPR Therapeutics AG -222.53 Million USD 95.377%
Precision BioSciences, Inc. -43.73 Million USD 76.479%
Fate Therapeutics, Inc. -190.51 Million USD 94.6%
Fortress Biotech, Inc. -142.34 Million USD 92.773%
Fortress Biotech, Inc. -142.34 Million USD 92.773%
HOOKIPA Pharma Inc. -97.69 Million USD 89.47%
ImmuCell Corporation -5.74 Million USD -78.964%
IDEAYA Biosciences, Inc. -134.42 Million USD 92.348%
Immix Biopharma, Inc. -16.14 Million USD 36.268%
Incyte Corporation 620.52 Million USD 101.658%
Innoviva, Inc. 176.7 Million USD 105.821%
IO Biotech, Inc. -91.44 Million USD 88.75%
Jaguar Health, Inc. -34.29 Million USD 70.001%
Keros Therapeutics, Inc. -169.94 Million USD 93.947%
Ligand Pharmaceuticals Incorporated 11.94 Million USD 186.141%
ContextLogic Inc. -328 Million USD 96.864%
MiMedx Group, Inc. 37.11 Million USD 127.716%
MEI Pharma, Inc. 14.54 Million USD 170.74%
NextCure, Inc. -67.63 Million USD 84.791%
Onconetix, Inc. -36.03 Million USD 71.452%
Oncternal Therapeutics, Inc. -41.71 Million USD 75.339%
Opthea Limited -191.84 Million USD 94.638%
Psyence Biomedical Ltd. -2.75 Million USD -273.825%
Vaxcyte, Inc. -468.04 Million USD 97.802%
PDS Biotechnology Corporation -43.04 Million USD 76.102%
Precigen, Inc. -88.92 Million USD 88.432%
Pharming Group N.V. -4.87 Million USD -110.819%
Phathom Pharmaceuticals, Inc. -167.31 Million USD 93.852%
Pieris Pharmaceuticals, Inc. -29.75 Million USD 65.429%
PureTech Health plc -146.19 Million USD 92.964%
Rigel Pharmaceuticals, Inc. -20.49 Million USD 49.797%
Avidity Biosciences, Inc. -235.59 Million USD 95.634%
Reviva Pharmaceuticals Holdings, Inc. -24.3 Million USD 57.678%
Sangamo Therapeutics, Inc. -274 Million USD 96.246%
Sol-Gel Technologies Ltd. -29.3 Million USD 64.897%
Acelyrin, Inc. -422.06 Million USD 97.563%
Salarius Pharmaceuticals, Inc. -12.89 Thousand USD -79675.478%
Summit Therapeutics Inc. -89.73 Million USD 88.536%
Sensei Biotherapeutics, Inc. -37.06 Million USD 72.245%
Senti Biosciences, Inc. -92.72 Million USD 88.906%
Stoke Therapeutics, Inc. -114.77 Million USD 91.037%
Elevation Oncology, Inc. -45.44 Million USD 77.364%
Alaunos Therapeutics, Inc. -34.26 Million USD 69.98%
Telomir Pharmaceuticals, Inc. Common Stock -3.94 Million USD -160.956%
Entrada Therapeutics, Inc. -3.16 Million USD -225.332%
VistaGen Therapeutics, Inc. -33.02 Million USD 68.847%
Kintara Therapeutics, Inc. -8.5 Million USD -21.009%
Wave Life Sciences Ltd. -67.99 Million USD 84.871%
Seer, Inc. -103.46 Million USD 90.057%
Verrica Pharmaceuticals Inc. -65.75 Million USD 84.357%
Aadi Bioscience, Inc. -71.93 Million USD 85.699%
ESSA Pharma Inc. -32.13 Million USD 67.987%
GlycoMimetics, Inc. -39.27 Million USD 73.808%
GT Biopharma, Inc. -13.57 Million USD 24.227%
Inhibrx Biosciences, Inc. -219.22 Million USD 95.307%
Akebia Therapeutics, Inc. -46.25 Million USD 77.761%
Catalyst Pharmaceuticals, Inc. 86.81 Million USD 111.85%
Longboard Pharmaceuticals, Inc. -56.75 Million USD 81.876%
Orchestra BioMed Holdings, Inc. -51.5 Million USD 80.028%
Alzamend Neuro, Inc. -9.93 Million USD -3.515%
Sorrento Therapeutics, Inc. -504.31 Million USD 97.96%
TRACON Pharmaceuticals, Inc. -6.89 Million USD -49.13%
Viracta Therapeutics, Inc. -50.69 Million USD 79.707%
Rocket Pharmaceuticals, Inc. -259.65 Million USD 96.038%
Aptose Biosciences Inc. -52.35 Million USD 80.352%
ZyVersa Therapeutics, Inc. -14.42 Million USD 28.665%
Soligenix, Inc. -7.69 Million USD -33.633%
Century Therapeutics, Inc. -146.54 Million USD 92.98%
Kura Oncology, Inc. -165.8 Million USD 93.796%
TScan Therapeutics, Inc. -93.45 Million USD 88.993%
Intensity Therapeutics, Inc. -8.31 Million USD -23.657%
Ocean Biomedical, Inc. -2.48 Million USD -314.524%
CytomX Therapeutics, Inc. -6.48 Million USD -58.652%
Autolus Therapeutics plc -195.02 Million USD 94.725%
Mineralys Therapeutics, Inc. -84.65 Million USD 87.849%
EyePoint Pharmaceuticals, Inc. -73.66 Million USD 86.035%
Eterna Therapeutics Inc. -21.13 Million USD 51.327%
Adaptive Biotechnologies Corporation -227.03 Million USD 95.469%
GRI Bio, Inc. -11.38 Million USD 9.66%
Xenetic Biosciences, Inc. -4.51 Million USD -127.804%
Tenaya Therapeutics, Inc. -131.19 Million USD 92.159%
IGM Biosciences, Inc. -263.46 Million USD 96.095%
INmune Bio, Inc. -29.74 Million USD 65.411%
Heron Therapeutics, Inc. -110.61 Million USD 90.7%
SAB Biotherapeutics, Inc. -38.07 Million USD 72.982%
Pasithea Therapeutics Corp. -15.97 Million USD 35.623%
Entero Therapeutics, Inc. -15.77 Million USD 34.772%
Milestone Pharmaceuticals Inc. -61.09 Million USD 83.163%
X4 Pharmaceuticals, Inc. -107.52 Million USD 90.433%
Atara Biotherapeutics, Inc. -276 Million USD 96.273%
Coherus BioSciences, Inc. -203.19 Million USD 94.937%
Verastem, Inc. -92.08 Million USD 88.829%
Abeona Therapeutics Inc. -47.13 Million USD 78.175%
Pliant Therapeutics, Inc. -184.14 Million USD 94.414%
Tonix Pharmaceuticals Holding Corp. -118.38 Million USD 91.31%
Histogen Inc. -10.64 Million USD 3.345%
Aprea Therapeutics, Inc. -15.47 Million USD 33.512%
Surrozen, Inc. -45.78 Million USD 77.529%
Organovo Holdings, Inc. -15.08 Million USD 31.811%
Lixte Biotechnology Holdings, Inc. -5.09 Million USD -102.093%
Ovid Therapeutics Inc. -59.28 Million USD 82.647%
Panbela Therapeutics, Inc. -51.29 Million USD 79.945%
CASI Pharmaceuticals, Inc. -25.28 Million USD 59.308%
Cadrenal Therapeutics, Inc. Common Stock -7.63 Million USD -34.773%
Centessa Pharmaceuticals plc -171.28 Million USD 93.994%
Hepion Pharmaceuticals, Inc. -48.44 Million USD 78.767%
Arcturus Therapeutics Holdings Inc. -78.2 Million USD 86.846%
BioRestorative Therapies, Inc. -15.22 Million USD 32.415%
Apollomics, Inc. -54.83 Million USD 81.24%
Amarin Corporation plc -67.58 Million USD 84.78%
Mesoblast Limited -58.79 Million USD 82.503%
Turnstone Biologics Corp. -59.03 Million USD 82.574%
Kymera Therapeutics, Inc. -165.53 Million USD 93.785%
Synaptogenix, Inc. -8.31 Million USD -23.733%
Tiziana Life Sciences Ltd -14.58 Million USD 29.473%
Aurinia Pharmaceuticals Inc. -91.69 Million USD 88.781%
BriaCell Therapeutics Corp. -4.79 Million USD -114.694%
Monopar Therapeutics Inc. -8.83 Million USD -16.484%
Exelixis, Inc. 170.88 Million USD 106.02%
Better Therapeutics, Inc. -38.26 Million USD 73.114%
Nurix Therapeutics, Inc. -155.06 Million USD 93.366%
Apellis Pharmaceuticals, Inc. -517.12 Million USD 98.011%
NLS Pharmaceutics AG -11.8 Million USD 12.874%
Dermata Therapeutics, Inc. -8.04 Million USD -27.917%
Aridis Pharmaceuticals, Inc. -29.99 Million USD 65.702%
Gritstone bio, Inc. -154.63 Million USD 93.348%
Jasper Therapeutics, Inc. -68.86 Million USD 85.061%
TNF Pharmaceuticals, Inc. -17.12 Million USD 39.923%
Avid Bioservices, Inc. -18.67 Million USD 44.925%
Insmed Incorporated -709.62 Million USD 98.55%
Virpax Pharmaceuticals, Inc. -15.68 Million USD 34.435%
MediWound Ltd. -15.29 Million USD 32.721%
OmniAb, Inc. -69.41 Million USD 85.181%
Alector, Inc. -151.74 Million USD 93.221%
Seres Therapeutics, Inc. -107.98 Million USD 90.474%
Checkpoint Therapeutics, Inc. -52.14 Million USD 80.273%
Zai Lab Limited -366.57 Million USD 97.194%
Revance Therapeutics, Inc. -316.77 Million USD 96.753%
Aura Biosciences, Inc. -84.99 Million USD 87.896%
Lyell Immunopharma, Inc. -245.49 Million USD 95.81%
Immunic, Inc. -99.22 Million USD 89.632%
Tarsus Pharmaceuticals, Inc. -143.15 Million USD 92.814%
Veracyte, Inc. -85.79 Million USD 88.01%
InMed Pharmaceuticals Inc. - USD Infinity%
FibroGen, Inc. -281.81 Million USD 96.35%
SeaStar Medical Holding Corporation -14.21 Million USD 27.607%
Adial Pharmaceuticals, Inc. -6.88 Million USD -49.348%
Sonnet BioTherapeutics Holdings, Inc. -18.79 Million USD 45.26%
Jazz Pharmaceuticals plc 578.58 Million USD 101.778%
Cyclacel Pharmaceuticals, Inc. -25.45 Million USD 59.584%
Amylyx Pharmaceuticals, Inc. 38.8 Million USD 126.512%
TG Therapeutics, Inc. 20.63 Million USD 149.857%
Galecto, Inc. -39.9 Million USD 74.221%
Calithera Biosciences, Inc. -42.07 Million USD 75.55%
Fortrea Holdings Inc. 63.1 Million USD 116.303%
KalVista Pharmaceuticals, Inc. -140.44 Million USD 92.675%
Aptevo Therapeutics Inc. -28.87 Million USD 64.378%
XBiotech Inc. -37.51 Million USD 72.575%
Jasper Therapeutics, Inc. -68.86 Million USD 85.061%
Lyra Therapeutics, Inc. -67.12 Million USD 84.674%
Foghorn Therapeutics Inc. -107.9 Million USD 90.467%
Y-mAbs Therapeutics, Inc. -25.67 Million USD 59.929%
Theravance Biopharma, Inc. -53.29 Million USD 80.697%
Ultragenyx Pharmaceutical Inc. -569.2 Million USD 98.193%
Metagenomi, Inc. Common Stock -78.49 Million USD 86.894%
Vaxxinity, Inc. -58.28 Million USD 82.351%
BioCryst Pharmaceuticals, Inc. -103.7 Million USD 90.081%
Gain Therapeutics, Inc. -22.25 Million USD 53.773%
Cartesian Therapeutics, Inc. -86.41 Million USD 88.096%
NexImmune, Inc. -29.19 Million USD 64.761%
Creative Medical Technology Holdings, Inc. -5.62 Million USD -83.038%
Marker Therapeutics, Inc. -14.58 Million USD 29.451%
Regeneron Pharmaceuticals, Inc. 4.04 Billion USD 100.254%
Chemomab Therapeutics Ltd. -25.45 Million USD 59.594%
Scopus BioPharma Inc. -11.71 Million USD 12.189%
RAPT Therapeutics, Inc. -127.06 Million USD 91.904%
Ainos, Inc. -13.2 Million USD 22.106%
Pluri Inc. -22.15 Million USD 53.574%
Prothena Corporation plc -191.03 Million USD 94.615%
Adaptimmune Therapeutics plc -138.03 Million USD 92.548%
Celularity Inc. -192.28 Million USD 94.65%
Rallybio Corporation -78.93 Million USD 86.967%
Cue Biopharma, Inc. -52.14 Million USD 80.274%
MeiraGTx Holdings plc -137.06 Million USD 92.495%
Omeros Corporation -164.53 Million USD 93.748%
Humacyte, Inc. -100.04 Million USD 89.718%
Immunocore Holdings plc -59.64 Million USD 82.754%
Cocrystal Pharma, Inc. -18.55 Million USD 44.571%
Cidara Therapeutics, Inc. -24.48 Million USD 57.983%
Blueprint Medicines Corporation -486.27 Million USD 97.885%
CalciMedica, Inc. -21.87 Million USD 52.974%
Cabaletta Bio, Inc. -74.66 Million USD 86.222%
Marinus Pharmaceuticals, Inc. -131.48 Million USD 92.176%
Scholar Rock Holding Corporation -171.29 Million USD 93.995%
Sana Biotechnology, Inc. -326.9 Million USD 96.853%
Pulmatrix, Inc. -14.74 Million USD 30.21%
Elicio Therapeutics, Inc. -35.74 Million USD 71.221%
Vigil Neuroscience, Inc. -88.86 Million USD 88.424%
Intellia Therapeutics, Inc. -515.29 Million USD 98.004%
Adlai Nortye Ltd. American Depositary Shares -67.55 Million USD 84.772%
Cytokinetics, Incorporated -496.2 Million USD 97.927%
Eloxx Pharmaceuticals, Inc. -34.41 Million USD 70.112%
Nutriband Inc. -4.87 Million USD -111.149%
Protara Therapeutics, Inc. -43.61 Million USD 76.413%
Vor Biopharma Inc. -126.03 Million USD 91.838%
Roivant Sciences Ltd. 4.24 Billion USD 100.243%
Evogene Ltd. -26.39 Million USD 61.021%
ProKidney Corp. -151.52 Million USD 93.211%
Applied Therapeutics, Inc. -64.53 Million USD 84.06%
Hoth Therapeutics, Inc. -7.69 Million USD -33.732%
BridgeBio Pharma, Inc. -607.37 Million USD 98.306%
CorMedix Inc. -48.95 Million USD 78.988%
BioLineRx Ltd. -49.69 Million USD 79.299%
Tango Therapeutics, Inc. -114.17 Million USD 90.99%
Galectin Therapeutics Inc. -38.07 Million USD 72.98%
Atai Life Sciences N.V. -125.47 Million USD 91.801%
Renovaro Biosciences Inc. -81.63 Million USD 87.399%
Aerovate Therapeutics, Inc. -81.4 Million USD 87.364%
Zentalis Pharmaceuticals, Inc. -248.98 Million USD 95.868%
Sagimet Biosciences Inc. -30.74 Million USD 66.535%
MediciNova, Inc. -9.9 Million USD -3.906%
Praxis Precision Medicines, Inc. -126.37 Million USD 91.86%
Cardio Diagnostics Holdings, Inc. -7.24 Million USD -42.037%
GeoVax Labs, Inc. -26.74 Million USD 61.534%
Axsome Therapeutics, Inc. -231.82 Million USD 95.563%
Biomea Fusion, Inc. -126.13 Million USD 91.844%
PTC Therapeutics, Inc. -349.4 Million USD 97.056%
Mereo BioPharma Group plc -28.41 Million USD 63.799%
Cullinan Oncology, Inc. -191.08 Million USD 94.617%
Syndax Pharmaceuticals, Inc. -229.95 Million USD 95.526%
Absci Corporation -115.51 Million USD 91.095%
NRx Pharmaceuticals, Inc. -27.58 Million USD 62.711%
4D Molecular Therapeutics, Inc. -112.86 Million USD 90.886%
Dyne Therapeutics, Inc. -242.16 Million USD 95.752%
Kiniksa Pharmaceuticals, Ltd. -25.19 Million USD 59.172%
Ventyx Biosciences, Inc. -207.99 Million USD 95.054%
Allakos Inc. -196.05 Million USD 94.753%
Imunon, Inc. -21.03 Million USD 51.085%
Fulcrum Therapeutics, Inc. -110.66 Million USD 90.704%
Corcept Therapeutics Incorporated 107.28 Million USD 109.589%
BioAtla, Inc. -129.68 Million USD 92.068%
NLS Pharmaceutics AG -11.8 Million USD 12.874%
Bio-Path Holdings, Inc. -15.84 Million USD 35.069%
Allogene Therapeutics, Inc. -327.73 Million USD 96.861%
Larimar Therapeutics, Inc. -41.75 Million USD 75.365%
XOMA Corporation -41.84 Million USD 75.418%
Kezar Life Sciences, Inc. -105.23 Million USD 90.225%
Cara Therapeutics, Inc. -121.49 Million USD 91.533%
aTyr Pharma, Inc. -54.91 Million USD 81.269%
Aligos Therapeutics, Inc. -87.42 Million USD 88.234%
Akero Therapeutics, Inc. -172.87 Million USD 94.049%
Viridian Therapeutics, Inc. -254.45 Million USD 95.957%
Eliem Therapeutics, Inc. -21.46 Million USD 52.078%
EyeGate Pharmaceuticals, Inc. -8.21 Million USD -25.256%
Akari Therapeutics, Plc -16.8 Million USD 38.79%
Tevogen Bio Holdings Inc. -8843.03 USD -116228.905%
Halozyme Therapeutics, Inc. 337.57 Million USD 103.047%
Lexaria Bioscience Corp. -6.53 Million USD -57.437%
UroGen Pharma Ltd. -65.53 Million USD 84.303%
Sutro Biopharma, Inc. -89.27 Million USD 88.478%
ZIVO Bioscience, Inc. -7.26 Million USD -41.635%
Orgenesis Inc. -53.63 Million USD 80.821%
Entera Bio Ltd. -8.89 Million USD -15.701%
GH Research PLC -41.22 Million USD 75.045%
Lisata Therapeutics, Inc. -25.7 Million USD 59.985%
Reneo Pharmaceuticals, Inc. -83.05 Million USD 87.614%
Xencor, Inc. -138.63 Million USD 92.58%
60 Degrees Pharmaceuticals, Inc. -5.15 Million USD -99.57%
Replimune Group, Inc. -234.77 Million USD 95.618%
Coeptis Therapeutics Holdings, Inc. -21.49 Million USD 52.134%
Vanda Pharmaceuticals Inc. -13.95 Million USD 26.269%
Lexaria Bioscience Corp. -6.53 Million USD -57.437%
Portage Biotech Inc. -18.25 Million USD 43.642%
Cardio Diagnostics Holdings, Inc. -7.24 Million USD -42.037%
Olema Pharmaceuticals, Inc. -104.96 Million USD 90.199%
OncoCyte Corporation -25.13 Million USD 59.075%
Qualigen Therapeutics, Inc. -11.3 Million USD 9.004%
Processa Pharmaceuticals, Inc. -11.45 Million USD 10.213%
Purple Biotech Ltd. 22.27 Million USD 146.19%
CollPlant Biotechnologies Ltd. -7.51 Million USD -36.941%
scPharmaceuticals Inc. -55.39 Million USD 81.43%
ProMIS Neurosciences, Inc. -18.89 Million USD 45.565%
HilleVax, Inc. -133.34 Million USD 92.285%
NeuroSense Therapeutics Ltd. -12.04 Million USD 14.624%
Tharimmune, Inc. -9.45 Million USD -8.797%
Genprex, Inc. -31.07 Million USD 66.897%
Neumora Therapeutics, Inc. Common Stock -188.19 Million USD 94.534%
Atossa Therapeutics, Inc. -31.37 Million USD 67.215%
XTL Biopharmaceuticals Ltd. -765 Thousand USD -1244.706%
Virios Therapeutics, Inc. -5.44 Million USD -88.859%
OKYO Pharma Limited -15.74 Thousand USD -65215.405%
Savara Inc. -60 Million USD 82.857%
Curis, Inc. -48.33 Million USD 78.716%
Daré Bioscience, Inc. -30.83 Million USD 66.644%
Carmell Therapeutics Corporation -5.21 Million USD -97.172%
Titan Pharmaceuticals, Inc. -7.27 Million USD -41.363%
Achieve Life Sciences, Inc. -27.25 Million USD 62.25%
BeiGene, Ltd. -1.2 Billion USD 99.148%
Kiromic BioPharma, Inc. -19.93 Million USD 48.408%
Revolution Medicines, Inc. Warrant -487.18 Million USD 97.888%
Protagonist Therapeutics, Inc. -93.65 Million USD 89.016%
Erasca, Inc. -141.52 Million USD 92.731%
bluebird bio, Inc. -244.26 Million USD 95.789%
Protagenic Therapeutics, Inc. -4.52 Million USD -127.238%
BioMarin Pharmaceutical Inc. 194.44 Million USD 105.291%
DBV Technologies S.A. -76.43 Million USD 86.541%
Protagenic Therapeutics, Inc. -4.52 Million USD -127.238%
Moderna, Inc. -4.23 Billion USD 99.757%
Vincerx Pharma, Inc. -42.6 Million USD 75.857%
Fresh Tracks Therapeutics, Inc. -6.36 Million USD -61.745%
Molecular Templates, Inc. -10.46 Million USD 1.71%
Acrivon Therapeutics, Inc. Common Stock -67.23 Million USD 84.7%
Travere Therapeutics, Inc. -376.74 Million USD 97.269%
Monte Rosa Therapeutics, Inc. -143.31 Million USD 92.822%
Spruce Biosciences, Inc. -51.99 Million USD 80.215%
Celldex Therapeutics, Inc. -154.54 Million USD 93.344%
Cogent Biosciences, Inc. -208.13 Million USD 95.057%
MacroGenics, Inc. -168.24 Million USD 93.886%
RenovoRx, Inc. -11.39 Million USD 9.731%
Adicet Bio, Inc. -152.03 Million USD 93.234%
Prime Medicine, Inc. -191.29 Million USD 94.622%
Aditxt, Inc. -26.06 Million USD 60.529%
Adagene Inc. -23.71 Million USD 56.631%
Estrella Immunopharma, Inc. -7.31 Million USD -40.723%
Quantum-Si incorporated -111.17 Million USD 90.747%
Maravai LifeSciences Holdings, Inc. -31.64 Million USD 67.496%
Acurx Pharmaceuticals, Inc. -14.57 Million USD 29.434%
Voyager Therapeutics, Inc. 122.01 Million USD 108.431%
SciSparc Ltd. -5.77 Million USD -78.192%
Vericel Corporation -6.46 Million USD -59.143%
Revelation Biosciences, Inc. -8.65 Million USD -18.833%
Minerva Neurosciences, Inc. -23.11 Million USD 55.505%
Generation Bio Co. -138.56 Million USD 92.576%
Astria Therapeutics, Inc. -83.03 Million USD 87.611%
Black Diamond Therapeutics, Inc. -86.46 Million USD 88.102%
Arcutis Biotherapeutics, Inc. -241.1 Million USD 95.733%
Invivyd, Inc. -207.78 Million USD 95.049%
Relay Therapeutics, Inc. -373 Million USD 97.242%
Quoin Pharmaceuticals, Ltd. -9.37 Million USD -9.687%
Spero Therapeutics, Inc. 21.48 Million USD 147.889%
2seventy bio, Inc. -216.7 Million USD 95.253%
ADMA Biologics, Inc. 21.63 Million USD 147.555%
Clene Inc. -40.54 Million USD 74.625%
Capricor Therapeutics, Inc. -24.07 Million USD 57.276%
Boundless Bio, Inc. Common Stock -54.79 Million USD 81.227%
GeoVax Labs, Inc. -26.74 Million USD 61.534%
Recursion Pharmaceuticals, Inc. -350.06 Million USD 97.061%
Citius Pharmaceuticals, Inc. -36.73 Million USD 71.994%
Contineum Therapeutics, Inc. Class A Common Stock 16.07 Million USD 163.986%
Relmada Therapeutics, Inc. -103.7 Million USD 90.08%
Finch Therapeutics Group, Inc. -34 Million USD 69.746%
ALX Oncology Holdings Inc. -170.27 Million USD 93.959%
Vir Biotechnology, Inc. -684.3 Million USD 98.497%
Evaxion Biotech A/S -22.19 Million USD 53.656%
Ocular Therapeutix, Inc. -82.38 Million USD 87.513%
Verve Therapeutics, Inc. -223.12 Million USD 95.39%
Trevena, Inc. -35.28 Million USD 70.848%
Surrozen, Inc. -45.78 Million USD 77.529%
Tyra Biosciences, Inc. -79.94 Million USD 87.132%
Cingulate Inc. -22.75 Million USD 54.801%
Galmed Pharmaceuticals Ltd. 7.49 Million USD 237.306%
Unity Biotechnology, Inc. -44.66 Million USD 76.97%
Tenax Therapeutics, Inc. -8.23 Million USD -24.934%
Terns Pharmaceuticals, Inc. -102.55 Million USD 89.97%
ACADIA Pharmaceuticals Inc. -73.37 Million USD 85.981%
Connect Biopharma Holdings Limited -62.07 Million USD 83.428%
Clearmind Medicine Inc. -8.74 Million USD -17.682%
Kronos Bio, Inc. -121.83 Million USD 91.556%
Bolt Biotherapeutics, Inc. -76.19 Million USD 86.499%
CERo Therapeutics Holdings, Inc. -2.93 Million USD -250.735%
Viking Therapeutics, Inc. -100.82 Million USD 89.797%
Statera Biopharma, Inc. -98.34 Million USD 89.54%
ImmunityBio, Inc. -362.25 Million USD 97.16%
Korro Bio, Inc. -84.53 Million USD 87.831%
Kineta, Inc. -15.72 Million USD 34.574%
BioVie Inc. -32.17 Million USD 68.033%
Codexis, Inc. -68.06 Million USD 84.887%
Celularity Inc. -192.28 Million USD 94.65%
Crinetics Pharmaceuticals, Inc. -222.6 Million USD 95.379%
Celcuity Inc. -66.23 Million USD 84.468%
Virax Biolabs Group Limited -6.49 Million USD -58.347%
Cibus, Inc. -318.88 Million USD 96.774%
Eledon Pharmaceuticals, Inc. -43 Million USD 76.077%
eFFECTOR Therapeutics, Inc. -33.84 Million USD 69.605%
IN8bio, Inc. -30.33 Million USD 66.091%
Kodiak Sciences Inc. -277.32 Million USD 96.291%
Annexon, Inc. -143.72 Million USD 92.842%
Adverum Biotechnologies, Inc. -123.79 Million USD 91.69%
Assembly Biosciences, Inc. -64.64 Million USD 84.087%
Avalo Therapeutics, Inc. -23.44 Million USD 56.121%
Ionis Pharmaceuticals, Inc. -353.73 Million USD 97.092%
Eyenovia, Inc. -25.4 Million USD 59.51%
Puma Biotechnology, Inc. 32.64 Million USD 131.517%
Conduit Pharmaceuticals Inc. -5.56 Million USD -84.951%
Xilio Therapeutics, Inc. -79.13 Million USD 87.0%
Arcellx, Inc. -89.88 Million USD 88.555%
Cardiff Oncology, Inc. -45.41 Million USD 77.347%
Enanta Pharmaceuticals, Inc. -137.2 Million USD 92.503%
Regulus Therapeutics Inc. -31.1 Million USD 66.932%
Moolec Science SA -6.65 Million USD -54.603%
Acumen Pharmaceuticals, Inc. -61.13 Million USD 83.174%
Geron Corporation -193.94 Million USD 94.696%
LAVA Therapeutics N.V. -43.25 Million USD 76.217%
Royalty Pharma plc 1.49 Billion USD 100.689%
Atea Pharmaceuticals, Inc. -164.16 Million USD 93.734%
Greenwich LifeSciences, Inc. -9.32 Million USD -10.282%
TFF Pharmaceuticals, Inc. -21.89 Million USD 53.016%
Mersana Therapeutics, Inc. -170.95 Million USD 93.983%
Humacyte, Inc. -100.04 Million USD 89.718%
Structure Therapeutics Inc. -102.77 Million USD 89.991%
89bio, Inc. -151.2 Million USD 93.197%
PMV Pharmaceuticals, Inc. -80.13 Million USD 87.162%
Avenue Therapeutics, Inc. -14.54 Million USD 29.25%
Genelux Corporation -24.16 Million USD 57.43%
Trevi Therapeutics, Inc. -33.92 Million USD 69.675%
Lexicon Pharmaceuticals, Inc. -171.75 Million USD 94.01%
Notable Labs, Ltd. -14.65 Million USD 29.815%
Liquidia Corporation -73.38 Million USD 85.982%
Mustang Bio, Inc. -50.72 Million USD 79.72%
Immunovant, Inc. -282.7 Million USD 96.361%
Quantum-Si incorporated -111.17 Million USD 90.747%
Arbutus Biopharma Corporation -78.1 Million USD 86.829%
DiaMedica Therapeutics Inc. -21.26 Million USD 51.629%
Vera Therapeutics, Inc. -102.01 Million USD 89.916%
Acasti Pharma Inc. -11.31 Million USD 9.061%
MiNK Therapeutics, Inc. -22.92 Million USD 55.12%
Pasithea Therapeutics Corp. -15.97 Million USD 35.623%
Xenon Pharmaceuticals Inc. -214.05 Million USD 95.194%
Elevai Labs, Inc. Common Stock -3.66 Million USD -180.371%
NeuroBo Pharmaceuticals, Inc. -15.88 Million USD 35.245%
Tempest Therapeutics, Inc. -29.15 Million USD 64.719%
Soleno Therapeutics, Inc. -41.38 Million USD 75.143%
PepGen Inc. -84.76 Million USD 87.864%
Moleculin Biotech, Inc. -29.63 Million USD 65.283%
United Therapeutics Corporation 1.18 Billion USD 100.868%
Nuvectis Pharma, Inc. -22.89 Million USD 55.073%
Solid Biosciences Inc. -104.31 Million USD 90.139%
BriaCell Therapeutics Corp. -32.8 Million USD 68.645%
Immuneering Corporation -58.41 Million USD 82.389%
Lixte Biotechnology Holdings, Inc. -5.09 Million USD -102.093%
Silo Pharma, Inc. -3.85 Million USD -166.807%
Belite Bio, Inc -31.66 Million USD 67.516%
XOMA Corporation -41.84 Million USD 75.418%
ARS Pharmaceuticals, Inc. -67.52 Million USD 84.765%
Bionomics Limited -17.89 Billion USD 99.943%
Apogee Therapeutics, Inc. -93 Million USD 88.939%
Alpha Tau Medical Ltd. 35.68 Million USD 128.831%
uniQure N.V. -282.87 Million USD 96.363%
Cassava Sciences, Inc. -105.95 Million USD 90.291%
Estrella Immunopharma, Inc. -7.31 Million USD -40.723%
Poseida Therapeutics, Inc. -129.5 Million USD 92.057%
Forte Biosciences, Inc. -32.48 Million USD 68.334%
Anebulo Pharmaceuticals, Inc. -8.3 Million USD -23.809%
Enlivex Therapeutics Ltd. -29.39 Million USD 65.004%
Conduit Pharmaceuticals Inc. -5.56 Million USD -84.951%
SeaStar Medical Holding Corporation -14.21 Million USD 27.607%
FibroBiologics, Inc. Common Stock -8.88 Million USD -15.727%
Altimmune, Inc. -95.92 Million USD 89.276%
Amicus Therapeutics, Inc. -73.49 Million USD 86.003%
Alpha Tau Medical Ltd. 35.68 Million USD 128.831%
Compugen Ltd. -12.99 Million USD 20.821%
Peak Bio, Inc. -1356.23 USD -758399.665%
Zevra Therapeutics, Inc. -49.6 Million USD 79.262%
Benitec Biopharma Inc. -22.49 Million USD 54.26%
Spyre Therapeutics, Inc. -242.3 Million USD 95.754%
NKGen Biotech, Inc. Common Stock -29.74 Million USD 65.417%
Zura Bio Limited -62.63 Million USD 83.577%
PolyPid Ltd. -22.86 Million USD 55.014%
Aileron Therapeutics, Inc. -16.27 Million USD 36.797%
NKGen Biotech, Inc. Warrants -29.74 Million USD 65.417%
Instil Bio, Inc. -159.16 Million USD 93.537%
argenx SE -425.04 Million USD 97.58%
Immunome, Inc. -109.53 Million USD 90.608%
Compass Therapeutics, Inc. -50.36 Million USD 79.574%
Verona Pharma plc -67.83 Million USD 84.834%
enGene Holdings Inc. Warrants -26.06 Million USD 60.526%
Shattuck Labs, Inc. -91.95 Million USD 88.813%
CervoMed Inc. -7.81 Million USD -31.667%
LENZ Therapeutics, Inc. -73.11 Million USD 85.929%
Plus Therapeutics, Inc. -13.32 Million USD 22.776%
Dianthus Therapeutics, Inc. -48.17 Million USD 78.646%
Moolec Science SA -6.65 Million USD -54.603%
Enveric Biosciences, Inc. -16.44 Million USD 37.459%
Inovio Pharmaceuticals, Inc. -135.22 Million USD 92.393%
AnaptysBio, Inc. -164.41 Million USD 93.743%
Design Therapeutics, Inc. -78.19 Million USD 86.844%
Leap Therapeutics, Inc. -87.04 Million USD 88.181%
NeurAxis, Inc. -6.66 Million USD -54.355%
Seelos Therapeutics, Inc. -40.49 Million USD 74.599%
Lumos Pharma, Inc. -36.61 Million USD 71.904%
Achilles Therapeutics plc -75.25 Million USD 86.33%
enGene Holdings Inc. Common Stock -26.06 Million USD 60.526%
180 Life Sciences Corp. -13.47 Million USD 23.673%
Opiant Pharmaceuticals, Inc. 5.15 Million USD 299.503%
CERo Therapeutics Holdings, Inc. -2.93 Million USD -250.735%
Nutriband Inc. -4.87 Million USD -111.149%
ORIC Pharmaceuticals, Inc. -110.78 Million USD 90.714%
CG Oncology, Inc. Common stock -55.44 Million USD 81.448%
Fractyl Health, Inc. Common Stock -50.83 Million USD 79.764%
Rani Therapeutics Holdings, Inc. -66.09 Million USD 84.437%
MoonLake Immunotherapeutics -54.12 Million USD 80.993%
Palisade Bio, Inc. -13.07 Million USD 21.293%
Tourmaline Bio, Inc. -45.4 Million USD 77.346%
Beam Therapeutics Inc. -176.48 Million USD 94.171%
Neurogene Inc. -55.58 Million USD 81.493%
Mirum Pharmaceuticals, Inc. -109.15 Million USD 90.576%
AEON Biopharma, Inc. -48.42 Million USD 78.759%
CARGO Therapeutics, Inc. Common Stock -96.71 Million USD 89.363%
Sesen Bio, Inc. -25.9 Million USD 60.296%
Enliven Therapeutics, Inc. -83.52 Million USD 87.685%
Kiora Pharmaceuticals, Inc. -12.58 Million USD 18.272%
Iovance Biotherapeutics, Inc. -460.55 Million USD 97.766%
Taysha Gene Therapies, Inc. -72.43 Million USD 85.799%
Athira Pharma, Inc. -125.46 Million USD 91.801%
Vaccinex, Inc. -22.88 Million USD 55.049%
HCW Biologics Inc. -25.71 Million USD 59.999%
XOMA Corporation -41.84 Million USD 75.418%
Nektar Therapeutics -137.42 Million USD 92.514%
Arvinas, Inc. -401.5 Million USD 97.438%
Tevogen Bio Holdings Inc. -8843.03 USD -116228.905%
Merus N.V. -156.54 Million USD 93.429%
Omega Therapeutics, Inc. -100.26 Million USD 89.74%
Quince Therapeutics, Inc. -34.62 Million USD 70.286%
Rezolute, Inc. -70.42 Million USD 85.393%
Clene Inc. -40.54 Million USD 74.625%
Indaptus Therapeutics, Inc. -16.37 Million USD 37.192%
BeyondSpring Inc. -23.11 Million USD 55.495%
Synlogic, Inc. -55.16 Million USD 81.351%
Allarity Therapeutics, Inc. -17.92 Million USD 42.624%
Phio Pharmaceuticals Corp. -10.82 Million USD 4.961%
Peak Bio, Inc. -1356.23 USD -758399.665%
Werewolf Therapeutics, Inc. -40.5 Million USD 74.602%
Krystal Biotech, Inc. -109.72 Million USD 90.625%
Karyopharm Therapeutics Inc. -129.53 Million USD 92.059%
SpringWorks Therapeutics, Inc. -343.01 Million USD 97.001%
Lipella Pharmaceuticals Inc. -4.74 Million USD -116.753%
MannKind Corporation 8.67 Million USD 218.541%
Ikena Oncology, Inc. -75.41 Million USD 86.36%
Cyclerion Therapeutics, Inc. -9.64 Million USD -6.634%
Gyre Therapeutics, Inc. -67.23 Million USD 84.699%
Gossamer Bio, Inc. -183.75 Million USD 94.402%
CohBar, Inc. -12.38 Million USD 16.962%
Cognition Therapeutics, Inc. -50.72 Million USD 79.72%
NRx Pharmaceuticals, Inc. -27.58 Million USD 62.711%
Legend Biotech Corporation -439.48 Million USD 97.659%
Mural Oncology plc -194.63 Million USD 94.715%
Biora Therapeutics, Inc. -67.14 Million USD 84.679%
PaxMedica, Inc. Common Stock -16.14 Million USD 36.285%
Disc Medicine, Inc. -91.12 Million USD 88.711%
Champions Oncology, Inc. -7.35 Million USD -39.845%
REGENXBIO Inc. -268.12 Million USD 96.163%
Ensysce Biosciences, Inc. -10.71 Million USD 4.023%
Anavex Life Sciences Corp. -55.75 Million USD 81.55%
Cellectar Biosciences, Inc. -38.96 Million USD 73.596%
Edgewise Therapeutics, Inc. -114.35 Million USD 91.004%
Vaxart, Inc. -83.34 Million USD 87.658%
PharmaCyte Biotech, Inc. -8.52 Million USD -20.739%
Aldeyra Therapeutics, Inc. -42.79 Million USD 75.962%
Cellectis S.A. -106.62 Million USD 90.352%
Longeveron Inc. -21.02 Million USD 51.082%
Repare Therapeutics Inc. -116.22 Million USD 91.149%
Sarepta Therapeutics, Inc. -267.82 Million USD 96.159%
Inozyme Pharma, Inc. -75.64 Million USD 86.401%
Revolution Medicines, Inc. -487.18 Million USD 97.888%
Nymox Pharmaceutical Corporation -6.65 Million USD -54.645%
Third Harmonic Bio, Inc. -43.95 Million USD 76.596%
ArriVent BioPharma, Inc. Common Stock -74.59 Million USD 86.209%
AN2 Therapeutics, Inc. -69.63 Million USD 85.227%
Anixa Biosciences, Inc. -11.01 Million USD 6.575%
Vertex Pharmaceuticals Incorporated 4.3 Billion USD 100.239%
Denali Therapeutics Inc. -196.69 Million USD 94.77%
Revelation Biosciences, Inc. -8.65 Million USD -18.833%
Veru Inc. -93.78 Million USD 89.031%
Corvus Pharmaceuticals, Inc. -23.32 Million USD 55.905%
Cingulate Inc. -22.75 Million USD 54.801%
Passage Bio, Inc. -108.38 Million USD 90.509%
Context Therapeutics Inc. -25.07 Million USD 58.971%
Exicure, Inc. -14.99 Million USD 31.402%
Day One Biopharmaceuticals, Inc. -206.06 Million USD 95.008%
Oramed Pharmaceuticals Inc. -40.59 Million USD 74.661%
Scinai Immunotherapeutics Ltd. -9.71 Million USD -5.867%
Rhythm Pharmaceuticals, Inc. -184.35 Million USD 94.42%
Nuvalent, Inc. -149.49 Million USD 93.119%
ABVC BioPharma, Inc. -8.21 Million USD -25.199%
Carisma Therapeutics, Inc. -88.73 Million USD 88.407%
Unicycive Therapeutics, Inc. -20.77 Million USD 50.481%
OmniAb, Inc. -69.41 Million USD 85.181%
Anew Medical, Inc. -1.3 Million USD -690.797%
Fennec Pharmaceuticals Inc. -12.77 Million USD 19.45%
Lipocine Inc. -17.93 Million USD 42.63%
Lexeo Therapeutics, Inc. Common Stock -68.51 Million USD 84.985%
Nautilus Biotechnology, Inc. -76.15 Million USD 86.491%
SAB Biotherapeutics, Inc. -38.07 Million USD 72.982%
G1 Therapeutics, Inc. -39.52 Million USD 73.975%
Bellerophon Therapeutics, Inc. -22.38 Million USD 54.043%
Sage Therapeutics, Inc. -579.84 Million USD 98.226%
Ocugen, Inc. -65.53 Million USD 84.302%
Mind Medicine (MindMed) Inc. -93.86 Million USD 89.041%
Q32 Bio Inc. -92.1 Million USD 88.831%
Brainstorm Cell Therapeutics Inc. -21.43 Million USD 52.017%
Alumis Inc. Common Stock -158.17 Million USD 93.496%
Equillium, Inc. -14.52 Million USD 29.163%
Kyverna Therapeutics, Inc. -62.4 Million USD 83.516%
Coya Therapeutics, Inc. -7.9 Million USD -30.16%
CNS Pharmaceuticals, Inc. -18.86 Million USD 45.471%
Galera Therapeutics, Inc. -46.95 Million USD 78.09%
Evelo Biosciences, Inc. -108.46 Million USD 90.516%
Comera Life Sciences Holdings, Inc. -11.97 Million USD 14.06%
Dominari Holdings Inc. -21.79 Million USD 52.803%
Edesa Biotech, Inc. -9.22 Million USD -11.539%
vTv Therapeutics Inc. -25.5 Million USD 59.662%
Bio-Techne Corporation 206.68 Million USD 104.977%
Agios Pharmaceuticals, Inc. -391.48 Million USD 97.372%
Harmony Biosciences Holdings, Inc. 192.03 Million USD 105.357%
Prelude Therapeutics Incorporated -132.27 Million USD 92.223%
Candel Therapeutics, Inc. -38.39 Million USD 73.205%
iTeos Therapeutics, Inc. -151.1 Million USD 93.192%
Nkarta, Inc. -131.65 Million USD 92.186%
BioCardia, Inc. -11.64 Million USD 11.654%
Iterum Therapeutics plc -47.46 Million USD 78.329%